Gerresheimer AG reagiert auf Medienberichte

Gerresheimer AG / Schlagwort(e): Fusionen & Übernahmen/Private Equity

Gerresheimer AG reagiert auf Medienberichte

17.06.2025 / 19:49 CET/CEST

Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News – ein Service der EQS Group.

Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Ende der Insiderinformation

Informationen und Erläuterungen des Emittenten zu dieser Mitteilung:

Hier zu Ihrer Information der entsprechende Medienbericht im Original:
KPS Is Said to End Talks With Warburg Pincus on Gerresheimer Bid
By Eyk Henning and Dinesh Nair
(Bloomberg) — KPS Capital Partners has decided against teaming up with Warburg Pincus on a potential joint bid for Gerresheimer AG, people familiar with the matter said, adding uncertainty to a deal for the German maker of packaging for drugs and cosmetics.
KPS has decided against pursuing a deal after holding discussions with Warburg Pincus and conducting due diligence, the people said, declining to be identified because the information is private. A bid from Warburg Pincus alone could prove difficult, some of the people said.
Shares of Gerresheimer have dropped more than a third this year, giving the company a market value of about€1.6 billion ($1.8 billion). The stock slumped 23% on June 2, the most since the global financial crisis in 2008,after the company cut its outlook and dividend.
Deliberations are ongoing and Warburg Pincus hasn’t made any final decisions on how it will proceed, thepeople said. Representatives for KPS, Warburg Pincus and Gerresheimer declined to comment.
Warburg Pincus was in discussions with KPS on a potential joint bid in the €70s for each Gerresheimer share, Bloomberg News reported last month. KPS was mainly interested in the company’s molded glass operations, people familiar with the matter said at the time.
Prior to the talks with KPS, Warburg Pincus had initially teamed up with KKR & Co. to pursue a deal for the German company, but KKR later walked away from the consortium, Bloomberg News reported in April.
Gerresheimer has been in the crosshairs for a takeover by buyout firms for years. It’s been seen as a prime breakup candidate due to the different nature of its two businesses. Its cosmetics arm makes plastic bottles and glass jars for perfume and skincare products, while its drug unit manufactures more complex packaging from syringes and glass vials to advanced products like injectors, inhalers and wearable infusors.
Dusseldorf-based Gerresheimer has separately been exploring strategic options for its molded glass business since last year.
To contact the reporters on this story: Eyk Henning in Frankfurt at ehenning1@bloomberg.net;

17.06.2025 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter https://eqs-news.com